Spring 2009, Dr. Betty Maloney, Minnesoto; Tim Lynagh, Legislative Director for Congressman Christopher Smith (NJ-4); and Pat Smith, President, Lyme Disease Association; in the office of Congressman Chris Smith (not pictured) after a meeting with NIH Lyme Disease Program officials on the problems with Lyme disease, a NIH Lyme research agenda, and how patients are […]
Govt. Departments & Agencies
The Government Department & Agencies section on the submenu includes federal government departments such as Health & Human Services (HHS), Department of Defense (DoD), and Department of Education (USDE). Often agencies under these departments adopt policies that affect Lyme & TBD, such as those from the CDC and NIH, both agencies are under HHS. The HHS Tick-Borne Disease Working group can be found under HHS. Military can be found under DoD. From time to time, the LDA will post articles in these sections that pertain to Lyme disease/TBD that might be of interest or importance to the public, including policies and rule making being considered or adopted.
Candy Brassard, Senior Biologist, U.S. Environmental Protection Agency Office of Pesticide Programs; C. Ben Beard, PhD, Director, Bacterial Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control & Prevention at a Meeting at EPA on Lyme in Virginia in 2006.
from Pat Smith, President, Lyme Disease Association, Inc. (LDA) www.LymeDiseaseAssociation.org IMPORTANT We need need your Congressman to co-sign letter for Lyme Department of Defense Money $$ Necessary Lyme Dollars for Research $$ HISTORY: A Dear Colleague letter has gone out from Congressmen Christopher Smith (NJ) and Bart Stupak (MI) to […]
TESTIMONY TO RHODE ISLAND STATE SENATE COMMERCE, HOUSING & MUNICIPAL GOVERNMENT COMMITTEE House Bill #H6136 Substitute A By Pat Smith, President, Lyme Disease Association, Inc. 6-26-03 I am President of the Lyme Disease Association, LDA, and sit on the board of directors of International Lyme and Associated Diseases Society, […]
Washinton, DC, meeting with Military at Office of Congressman Christopher Smith Washinton, DC, meeting with Military at Office of Congressman Christopher Smith By Pat Smith, President, Lyme Disease Association, Inc. 9-18-02 I am President of the Lyme Disease Association, LDA, an all-volunteer national organization providing Lyme disease education and funding for research projects […]
Tuesday, September 17, 2002 Press Release SOURCE: Lyme Disease Association CONGRESSMAN TAKES AIM AT LYME DISEASE IN THE MILITARY Lyme Disease Association urges higher education for physicians ROBBINSVILLE, NJ –- September 16, 2002- Rising concern over debilitating cases of Lyme disease that go undiagnosed has led the Lyme Disease Association (LDA) to initiate a meeting […]
The first portion of this article first appeared in Tiny Tick Tales published by the Lyme Disease Association of New Jersey (LDANJ), now Lyme Disease Association. The second article appeared in the Lyme Times. Updates follow each piece. This entire article appeared in the Time for Lyme Newsletter. May 1999 THE LDANJ VISITS THE US […]
REMARKS OF PAT SMITH, PRESIDENT, LYME DISEASE ASSOCIATION, INC. BEFORE THE VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE, MAY 21, 2002. Why more adverse events were seen after the vaccine reached the market: People receiving Lymerix after product launch lived in Lyme-endemic areas. REMARKS OF PAT SMITH, PRESIDENT, LYME DISEASE ASSOCIATION, INC. BEFORE […]
SPECIAL REPORT: LDA MEETS WITH FDA ON LYMERIX On January 22, 2002 in Bethesda, MD., the LDA was able to get a private meeting with the FDA on the vaccine issue, despite reluctance by the FDA to grant the meeting. Congressman Chris Smith helped facilitate the setup of this meeting. Patricia Smith, President, Lyme […]
I am here today because we do favor a safe and effective vaccine, but we are unsure whether an OSP A based vaccine can meet those criteria. Since the inception of OSP A vaccine trials, we heard from individuals experiencing difficulties after immunization. The information was startling, not only because of the problems described, but […]
Assays for Antibodies to Borrelia burgdorferi; Limitations, Use, and Interpretation for Supporting a Clinical Diagnosis of Lyme Disease July 7, 1997 Purpose FDA is advising you about the potential for misdiagnosis of Lyme disease. The results of commonly marketed assays for detecting antibody to Borrelia burgdorferi (anti-Bb), the organism that causes Lyme disease, may be […]